Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya
Clinical trial NCT02325440 · UNKNOWN
Trial details
- NCT number
- NCT02325440
- Sponsor
- University Hospital Muenster
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-04-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.